TFPI2 in tumor metastasis: a double-edged sword with clinical implications

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Tissue factor pathway inhibitor 2 (TFPI2) is a serine protease inhibitor with known roles in tumor metastasis.
• Traditionally considered a metastasis suppressor, TFPI2 inhibits extracellular matrix remodeling, epithelial-mesenchymal transition, and angiogenesis.

Purpose of the Study:

• To review the context-dependent functions of TFPI2 in cancer metastasis.
• To explore the regulatory mechanisms, structural duality, microenvironmental heterogeneity, and receptor differences underlying TFPI2's opposing roles.
• To evaluate TFPI2 as a potential therapeutic target.

Main Methods:

• Literature review summarizing existing research on TFPI2's role in various cancers.
• Analysis of structural and microenvironmental factors influencing TFPI2 activity.
• Evaluation of therapeutic potential based on current understanding.

Main Results:

• TFPI2 exhibits context-dependent opposing functions, acting as both a metastasis suppressor and promoter in different cancers (e.g., glioblastoma, melanoma).
• Emerging evidence shows TFPI2 can promote tumor progression by creating an immunosuppressive tumor microenvironment, pathological ECM remodeling, and enhancing angiogenesis and dissemination.
• Divergent expression patterns and context-specific functions are observed within the same metastatic cascade.

Conclusions:

• TFPI2's role in cancer metastasis is complex and highly context-dependent.
• Understanding TFPI2's structural duality and microenvironmental interactions is crucial for its therapeutic application.
• Future research focusing on spatiotemporal microenvironmental dynamics is needed for precise intervention and early screening.